Reopening comment period for Framework for a Real-World Evidence Program

The Food and Drug Administration will reopen the comment period for 60 days for the notice entitled “Framework for a Real-World Evidence Program; Availability” (Docket No. FDA-2018-N-4000).

Contact Information:
Dianne Paraoan
Center for Drug Evaluation and Research
Food and Drug Administration
10903 New Hampshire Avenue
Bldg. 51, Rm. 3326
Silver Spring, MD 20993
Tel: 301-796-2500
Email: dianne.paraoan@fda.hhs.gov